(ECNS) MSCI China Small-Cap - Overview
Etf: Consumer, Technology, Industrials, Healthcare
Dividends
| Dividend Yield | 6.27% |
| Yield on Cost 5y | 4.12% |
| Yield CAGR 5y | -3.44% |
| Payout Consistency | 89.4% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 25.9% |
| Relative Tail Risk | -6.44% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.42 |
| Alpha | 34.84 |
| Character TTM | |
|---|---|
| Beta | 0.677 |
| Beta Downside | 0.621 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.53% |
| CAGR/Max DD | 0.06 |
Description: ECNS MSCI China Small-Cap December 22, 2025
The iShares MSCI China Small-Cap ETF (ECNS) aims to track a free-float-adjusted, market-cap weighted index that captures the performance of Chinese small-cap equities listed as H-shares and B-shares. At least 80% of the fund’s assets are invested in the index’s component securities or in securities with substantially identical economic characteristics.
As of the latest reporting, ECNS holds roughly 250 stocks with a weighted average market cap of about ¥150 billion, and its top sector exposures are consumer discretionary, technology, and health care-areas that have benefited from China’s ongoing urbanization and rising middle-class consumption. The fund’s expense ratio is 0.65%, and its assets under management have grown to roughly $1.2 billion, reflecting heightened investor interest in the country’s small-cap growth story amid a 5-year average GDP growth rate of 5.8%.
For a deeper dive into how ECNS fits into a diversified China-focused portfolio, you might explore the detailed analytics available on ValueRay.
What is the price of ECNS shares?
Over the past week, the price has changed by +3.92%, over one month by +4.07%, over three months by +2.69% and over the past year by +42.51%.
Is ECNS a buy, sell or hold?
What are the forecasts/targets for the ECNS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 40.6 | 13.6% |
ECNS Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 96.7m USD (96.7m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 96.7m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 96.7m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.41% (E(96.7m)/V(96.7m) * Re(8.41%) + (debt-free company))
Discount Rate = 8.41% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)